2021-09-29-深交所-稳健医疗_2021年半年度报告(英文版)_284页_4mb
报告摘要
2021 Winner Medical Co., Ltd. Semi-annual Report Summary
Core Content Overview
This report provides an overview of Winner Medical Co., Ltd.'s financial performance and operational activities for the first half of 2021. It includes important notes, company profile, management discussion and analysis, corporate governance, environmental protection, and other relevant sections. The report outlines the Company's main business segments, financial indicators, and strategic initiatives, while also highlighting the risks and challenges it may face.
Main Financial Indicators
I. Financial Performance
- Revenue: 4,059,865,654.92 yuan (down by 2.87% compared to the same period in 2020)
- Net profits attributable to shareholders: 761,038,730.24 yuan (down by 26.27%)
- Net profits after non-recurring items: 627,255,609.19 yuan (down by 38.68%)
- Net cash flow from operating activities: 197,604,865.77 yuan (down by 92.01%)
- Basic EPS: 1.7844 yuan/share (down by 34.92%)
- Diluted EPS: 1.7715 yuan/share (down by 35.39%)
- Weighted average return on net assets: 7.06% (down by 21.27% compared to the previous year)
II. Financial Position
- Total assets: 13,112,976,247.91 yuan (up by 0.85% from the end of the previous year)
- Net assets attributable to shareholders: 10,518,676,503.69 yuan (up by 0.62%)
Company Profile
- Stock abbreviation: Winner Medical
- Stock code: 300888
- Stock exchange: Shenzhen Stock Exchange
- Company name in Chinese: Winner Medical Co., Ltd.
- Legal representative: Li Jianquan
Contact Information
- Board of Directors Secretary: Chen Huixuan
- Securities Affairs Representative: Wei Na, Liu Yanxiang
- Contact address: F42, Building 2, Huilong Business Center, Shenzhen North Railway Station Area, Minzhi Subdistrict, Longhua District, Shenzhen City
- Tel: 0755-28066858
- Fax: 0755-28134688
- Email: investor@winnermedical.com
- Website: http://www.winnermedical.cn, http://www.winnermedical.com
- Date of interim announcement disclosure: April 20, 2021
- Query index: http://www.cninfo.com.cn/new/index
Key Entities and Definitions
| Term | Refers to |
|---|---|
| Winner Medical | Winner Medical Co., Ltd. |
| Winner Group | Winner Group Limited, a controlling shareholder |
| Sequoia Xinyuan | Beijing Sequoia Xinyuan Equity Investment Center (L.P.) |
| Kangsheng Investment | Shenzhen Kangsheng Investment Partnership (L.P.) |
| Kangxin Investment | Shenzhen Kangxin Investment Partnership (L.P.) |
| SCGC | Shenzhen Capital Group Co., Ltd. |
| Kanglong Investment | Shenzhen Kanglong Investment Partnership (L.P.) |
| Kangli Investment | Shenzhen Kangli Investment Partnership (L.P.) |
| Winner Medical (Chongyang) | Winner Medical (Chongyang) Co., Ltd., a wholly-owned subsidiary |
| Winner Medical (Jiayu) | Winner Medical (Jiayu) Co., Ltd., a wholly-owned subsidiary |
| Winner Medical (Jingmen) | Winner Medical (Jingmen) Co., Ltd., a wholly-owned subsidiary |
| Winner Medical (Yichang) | Yichang Winner Medical Textile Co., Ltd., a wholly-owned subsidiary |
| Winner Medical (Huanggang) | Winner (Huanggang) Cotton Processing & Trading Co., Ltd., a wholly-owned subsidiary |
| Winner Medical Malaysia | Winner Medical Malaysia Sdn. Bhd., a subsidiary controlled by the Company |
| Winner Medical (Hong Kong) | Winner Medical (Hong Kong) Ltd., a subsidiary controlled by the Company |
| Winner Medical (Heyuan) | Winner Medical (Heyuan) Co., Ltd., a wholly-owned subsidiary |
| Winner Medical (Wuhan) | Winner Medical (Wuhan) Co., Ltd., a wholly-owned subsidiary |
| Pure HB (Shanghai) | Pure HB (Shanghai) Co., Ltd., a wholly-owned subsidiary |
| PureH2B | Shenzhen PureH2B Technology Co., Ltd., a wholly-owned subsidiary |
| Tmall | An integrated online B2C shopping platform under Alibaba Group |
| JD.com | Beijing Jingdong Century Trading Co., Ltd., a company listed on U.S. exchanges |
Main Business Overview
I. Medical Consumables Section
Winner Medical is a leading company in the medical consumables industry, offering a wide range of products including:
- Wound care products: Traditional wound care and high-end wound dressing products (e.g., gauze sheets, non-woven sheets, silicone dressings, alginate dressings)
- Infection prevention products: Operating room infection control products (e.g., surgical packs, surgical gowns) and disease prevention and control products (e.g., masks, protective clothing, isolation gowns)
- Disinfection & cleaning products: Cotton swabs, cotton pads, cotton balls, alcohol cotton pads, disinfectant
The company has established a full industrial chain covering cotton procurement, R&D, production, and direct export. Its products are certified by EU CE, US FDA, and Japanese Ministry of Health, Labour and Welfare and are exported to Europe, America, and Japan. The "Winner" brand has been well-received for its quality and service, especially during the pandemic, with a focus on reducing nosocomial infections through disposable operating room consumables.
II. Healthy Consumer Goods Section
The Purcotton brand focuses on non-woven consumer goods and textile products, emphasizing "Medical background/Purcotton philosophy/Quality in our DNA". Its product range includes:
- Non-woven consumer goods: Pure cotton tissues, wet tissues, sanitary pads
- Textile consumer goods: Baby supplies, baby clothing, adult clothing, home textile products
Purcotton promotes a "comfort, health, environmental protection" lifestyle, using cotton as the primary raw material and offering medical-grade quality products. The brand also provides overall solutions for different life scenes, including personal care, home care, and maternal and child care.
III. PureH2B Brand
Launched in July 2019, the PureH2B brand aims to build a one-stop retail platform for beauty makeup, personal care, sports, and other healthy and beautiful life needs. As of June 30, 2020, it had 9 offline stores, an official website, and WeChat mini programs, with its business still in the early stages.
Main Operating Modes
1. Procurement Mode
- The company has a complete procurement management system.
- Purchase applications are submitted based on customer orders, sales plans, and production plans.
- Key raw materials (e.g., cotton and veil) are procured uniformly under strategic guidelines.
- A strict supplier management system ensures product quality and stable supply.
- The company maintains a Qualified Supplier Directory with dynamic updates and elimination.
2. Production Mode
- Production plans are based on customer orders, annual sales plans, and monthly rolling sales plans.
- The company uses Make to Order (MTO) and Made to Stock (MTS) strategies depending on demand and capacity.
3. Sales Mode
- The company utilizes multiple sales channels, including:
- Offline stores
- Online official websites
- WeChat mini programs
4. Marketing Mode
- The company promotes its brands (Winner, Purcotton, PureH2B) through coordinated marketing efforts.
- Brand marketing relies heavily on its reputation and product quality.
- Purcotton uses differentiated strategies to build its brand identity.
Non-Recurring Profit and Loss Items
The company reported the following non-recurring profit and loss items (in yuan):
| Item | Amount | Description |
|---|---|---|
| Disposal of non-current assets | (7,991,363.76) | Including asset impairment write-offs |
| Government subsidies | 86,791,122.28 | Excluding those closely related to core business |
| Fair value changes and investment income | 79,825,882.59 | From tradable financial assets and liabilities |
| Other income and expenditure | 1,756,948.93 | |
| Less: Tax effect | (26,599,643.40) | |
| Minority shareholders' equity (after tax) | (174.41) | |
| Total | 133,783,121.05 | -- |
The company did not define any non-recurring profit and loss items according to Interpretative Announcement No. 1 on Information Disclosure of Public Securities Issuing Companies.
Risks and Countermeasures
- The report highlights the main risks the company may face in the future, particularly in Section 3 Management Discussion and Analysis, under "12. Risks and countermeasures".
- These risks are not profit forecasts but are planned matters, influenced by market changes and other external factors.
- Investors are advised to be aware of these risks and understand the differences between plans, forecasts, and commitments.
Key Notes
- The company does not plan to distribute cash dividends, transfer shares, or increase the share capital of the common reserve fund.
- The semi-annual report is available for inspection at the Securities Department of the Company.
- The report includes all publicly disclosed company documents and announcements from the reporting period.
- The company's registered and office addresses, as well as its official website and email, have not changed during the reporting period.
- The company has not changed its information disclosure practices or registration status during the reporting period.
试读结束,高清完整版pdf/doc/ppt,请点下载